CIK 0001372514
- Non-accelerated filer
- Smaller reporting company
KIORA PHARMACEUTICALS INC
Sign in to watch- Tickers
- KPRX KPHMW
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 980443284
- Phone
- +1 858-224-9600
- Business address
- 169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
- Former names
- EYEGATE PHARMACEUTICALS INC
Securities
- KPRX Common Stock Nasdaq
- KPHMW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-14 | MANZO MICHAEL P. VP of Engineering | Grant or award | +7,500 | 18,421 | ||
| 2020-02-14 | MANZO MICHAEL P. VP of Engineering | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-02-14 | Mann Brenda VP of Research & Development | Grant or award | +7,500 | 18,398 | ||
| 2020-02-14 | Mann Brenda VP of Research & Development | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2020-02-14 | MALFROY-CAMINE BERNARD Director | Grant or award · Stock Option (right to buy) | +3,333 | 3,333 | ||
| 2020-02-10 | ARMISTICE CAPITAL, LLC Director | Purchase | +12,000 | $6.04 | $72K | 1,815,500 |
| 2020-02-10 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 1,815,500 | ||
| 2020-02-06 | ARMISTICE CAPITAL, LLC Director | Purchase | +11,000 | $6.18 | $68K | 1,803,500 |
| 2020-02-06 | ARMISTICE CAPITAL, LLC Director | Purchase | +0 | 1,803,500 | ||
| 2020-02-04 | FROM STEPHEN President and CEO | Shares withheld for taxes | −584 | $6.00 | $4K | 64,329 |
| 2020-02-04 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −109 | $6.00 | $654 | 10,921 |
| 2020-02-04 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −109 | $6.00 | $654 | 10,898 |
| 2020-02-04 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −109 | $6.00 | $654 | 16,742 |
| 2020-01-03 | FROM STEPHEN President and CEO | Shares withheld for taxes | −730 | $9.52 | $7K | 64,913 |
| 2020-01-03 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −119 | $9.52 | $1K | 11,007 |
| 2020-01-03 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −119 | $9.52 | $1K | 16,851 |
| 2020-01-03 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −119 | $9.52 | $1K | 11,030 |
| 2019-12-18 | Romano Sarah Chief Financial Officer | Shares withheld for taxes | −101 | $7.46 | $753 | 16,970 |
| 2019-12-18 | Mann Brenda VP of Research & Development | Shares withheld for taxes | −101 | $7.46 | $753 | 11,126 |
| 2019-12-18 | MANZO MICHAEL P. VP of Engineering | Shares withheld for taxes | −101 | $7.46 | $753 | 11,149 |
Page 12 of 13 · 244 trades